Cookies

Like most websites The Pathologist uses cookies. In order to deliver a personalized, responsive service and to improve the site, we remember and store information about how you use it. Learn more.

Search

Reset Filter

1653 search results for ‘*’


Outside the Lab Profession

Quote of the Month

| Christopher D.M. Fletcher

What do you do when you come across a case that you can't solve? There isn't always an answer for everything, according to these words of wisdom


Outside the Lab Profession

Come on Pathology, Light My Fire

| Luke Turner

After Michael Misialek contacted Robby Krieger of legendary rock band The Doors, they teamed up to raise crucial funds – and awareness – for pathology


Outside the Lab Profession

Five Years and Counting

| Michael Schubert

How has pathology changed over the last five years – and what doesn’t seem to have changed at all?

Outside the Lab Profession

A Day in the Life of Jim Lanier

Jim Lanier enjoyed a successful 33-year career in pathology – but he now fills his time with an usual yet thrilling hobby in Alaska!

Diagnostics Companion diagnostics

Atezolizumab Assay Angst

| David Rimm

David Rimm continues the conversation about the best assay for atezolizumab after a recent response to his original article

Inside the Lab Digital and computational pathology

Mutation Detective

| Luke Turner

A new algorithm finds that a quality control process to remove nonsense mutations in our immune system could be having an undesired effect

Diagnostics Histology

Case of the Month

Case of the Month is back for 2020! Can you diagnose this 71-year-old female who presented with an incidental osseous nasal septum mass?

Outside the Lab Technology and innovation

Midas Touch or Fool’s Gold?

| Richard Huang, Veronica Klepeis

The FDA has introduced new regulatory frameworks to ease digital medical devices’ transition to market – so why aren’t pathology companies using them?

Outside the Lab Profession

Winter of Discontent

| Simon Parker

Healthcare services face mounting pressures each winter – but rapid, reliable diagnostics can help

Subspecialties Neurology

Predicting Prognosis in Glioblastoma

| Luke Turner

A link between cfDNA concentration and progression-free survival in glioblastoma patients supports the use of liquid biopsy when predicting prognosis

Register to The Pathologist

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:

  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Pathologist magazine

Register